Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Treatment of Refractory Prurigo Nodularis With Lenalidomide

Treatment of Refractory Prurigo Nodularis With Lenalidomide THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; RUTH ANN VLEUGELS, MD Treatment of Refractory Prurigo Nodularis With Lenalidomide Holly Kanavy, DO; Jennifer Bahner, MD; Neil J. Korman, MD, PhD; Department of Dermatology, University Hospitals Case Medical Center, Cleveland, Ohio Prurigo nodularis is an intensely pruritic disorder in which ter 18 months of therapy, which necessitated discon- chronic scratching and rubbing lead to the formation of tinuation of thalidomide. Other therapies used in- eroded and excoriated skin nodules that may become gen- cluded capsaicin cream, oral naltrexone (50 mg/d) for 2 eralized. Therapy for prurigo nodularis is notoriously dif- months, minocycline (100 mg twice daily) for 4 months, ficult, and relief of pruritus and clearing of the skin le- and gabapentin (600 mg 3 times daily) for 3 months, none sions is exceedingly difficult to achieve. of which led to any improvement. In addition, owing to the availability of sample medication, we treated her with a 12-week course of intramuscular alefacept (15 mg/ REPORT OF A CASE wk), a 12-week course of subcutaneous etanercept (50 mg twice weekly), and intralesional alefacept (10 mg/ A 45-year-old http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Dermatology American Medical Association

Treatment of Refractory Prurigo Nodularis With Lenalidomide

JAMA Dermatology , Volume 148 (7) – Jul 1, 2012

Loading next page...
 
/lp/american-medical-association/treatment-of-refractory-prurigo-nodularis-with-lenalidomide-Rkkx4GSNPi
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6068
eISSN
2168-6084
DOI
10.1001/archdermatol.2011.2918
pmid
22801610
Publisher site
See Article on Publisher Site

Abstract

THE CUTTING EDGE: CHALLENGES IN MEDICAL AND SURGICAL THERAPIES SECTION EDITOR: EDWARD W. COWEN, MD, MHSc; ASSISTANT SECTION EDITORS: MURAD ALAM, MD; RUTH ANN VLEUGELS, MD Treatment of Refractory Prurigo Nodularis With Lenalidomide Holly Kanavy, DO; Jennifer Bahner, MD; Neil J. Korman, MD, PhD; Department of Dermatology, University Hospitals Case Medical Center, Cleveland, Ohio Prurigo nodularis is an intensely pruritic disorder in which ter 18 months of therapy, which necessitated discon- chronic scratching and rubbing lead to the formation of tinuation of thalidomide. Other therapies used in- eroded and excoriated skin nodules that may become gen- cluded capsaicin cream, oral naltrexone (50 mg/d) for 2 eralized. Therapy for prurigo nodularis is notoriously dif- months, minocycline (100 mg twice daily) for 4 months, ficult, and relief of pruritus and clearing of the skin le- and gabapentin (600 mg 3 times daily) for 3 months, none sions is exceedingly difficult to achieve. of which led to any improvement. In addition, owing to the availability of sample medication, we treated her with a 12-week course of intramuscular alefacept (15 mg/ REPORT OF A CASE wk), a 12-week course of subcutaneous etanercept (50 mg twice weekly), and intralesional alefacept (10 mg/ A 45-year-old

Journal

JAMA DermatologyAmerican Medical Association

Published: Jul 1, 2012

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month